Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis

Clinical trial NCT05433207 · UNKNOWN

Trial details

NCT number: NCT05433207
Sponsor: Chugai Pharmaceutical
Status: UNKNOWN
Study type: OBSERVATIONAL

Postmenopausal Osteoporosis

Start date: 2022-08-01
Primary completion: 2025-01-31
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.